BSPED would like to thank all of its corporate supporters:
Partner Level
 |
Novo Nordisk
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 43,100 people in 79 countries and markets its products in more than 170 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.
Gold Sponsor
 |
Diurnal
Diurnal is an innovative UK-based specialty pharmaceutical company dedicated to developing high quality hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions. Since inception in 2004, our company mission has been clear: to address crucial unmet patient and clinical need in the endocrine field and deliver best health outcomes to improve patients’ quality of life.
We wish everyone at BSPED 2018 a successful meeting; come and visit us at our stand.
 |
Sandoz
Sandoz, a Division of the Novartis Group, is a global leader in generic and biosimilar medicines. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.
 |
Alexion
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. As the global leader in complement inhibition, Alexion is strengthening and broadening its portfolio of complement inhibitors. In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas.
 |
Merck
Merck is a leading science and technology company in healthcare, life science and
performance materials. Around 50,000 employees work to further develop technologies
that improve and enhance life – from biopharmaceutical therapies to treat cancer or
multiple sclerosis, cutting-edge systems for scientific research and production, to liquid
crystals for smartphones and LCD televisions. In 2016, Merck generated sales of €15.0 billion
in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The
founding family remains the majority owner of the publicly listed corporate group. Merck
holds the global rights to the Merck name and brand. The only exceptions are the United
States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD
Performance Materials.
Exhibitor
 |
 |
 |
 |
 |
 |
  |
   |
|
 |
 |
|
 |
Patient Support Groups
 |
 |
 |
 |
 |
 |
 |
 |
Sponsor and Exhibitor forms